Turkish Journal of Nephrology
Original Article

Approaches of Pediatric Nephrologists to Hypertensive Patients in Turkey (Turkish Pediatric Hypertension Working Group Study)


Department of Pediatric Nephrology, İzmir Katip Çelebi University, İzmir, Turkey


Department of Pediatric Nephrology, İzmir Tepecik Training and Research Hospital, İzmir, Turkey


Division of Pediatric Nephrology, Koç University School of Medicine, İstanbul, Turkey


Division of Pediatric Nephrology, Bahçeşehir University School of Medicine, İstanbul, Turkey


Division of Pediatric Nephrology, Pamukkale University School of Medicine, Denizli, Turkey


Division of Pediatric Nephrology, Okmeydanı Training and Research Hospital, Istanbul, Turkey


Division of Pediatric Nephrology, Altınbaş University School of Medicine, İstanbul Memorial Bahçelievler Hospital, İstanbul, Turkey


Division of Pediatric Nephrology, Yeniyüzyıl University Gaziosmanpaşa Hospital, İstanbul, Turkey


Division of Pediatric Nephrology, Anadolu Medical Center Hospital, Kocaeli, Turkey


Division of Pediatric Nephrology, Trakya University School of Medicine, Edirne, Turkey


Division of Pediatric Nephrology, Adnan Menderes University School of Medicine, Aydın, Turkey

Turkish J Nephrol 2022; 31: 110-115
DOI: 10.5152/turkjnephrol.2022.21112
Read: 95 Downloads: 33 Published: 01 April 2022

Objective: We aimed to evaluate the approaches of pediatric nephrologists in our country to the management of childhood hypertension.

Methods: The pediatric nephrologists in our country were invited to fill out an online questionnaire including 24 questions. The answers were compared between those working in the field for ≤10 years (Group 1, n =74) and >10 years (Group 2, n = 62).

Results: Of 136 participants (M/F = 101/35), 52% were following a single guideline [31% Fourth Report of 2004, 17% European Society of Hypertension in 2016, and 52% American Academy of Pediatrics in 2017], which is more common in Group 1 (P = .035). The most commonly used guideline was American Academy of Pediatrics of 2017 and Group 2 used Fourth Report of 2004 more commonly (P = .042). The most common choice to diagnose hypertension was office +home +ambulatory blood pressure monitoring (59%). The frequency of screening for end-organ damage at first evaluation was 96%. The time to wait for the effect of lifestyle modifications was 3 months in 52%. The first choice medication was angiotensin-converting enzyme inhibitors (49%) or calcium-channel blockers (48%) in non-obese and angiotensin-converting enzyme inhibitors (74%) in obese children. Calcium-channel blockers were more commonly prescribed as the first choice in non-obese children in Group 1 (P = .035). The most accessible emergency drug was esmolol.

Conclusion: Despite following recent guidelines, the time spent in the proficiency would change the practices.

Cite this article as: Kasap-Demir B, Taşdemir M, Övünç-Hacıhamdioğlu D, et al. Approaches of pediatric nephrologists to hypertensive patients in Turkey (Turkish Pediatric Hypertension Working Group Study). Turk J Nephrol. 2022;31(2):110-115.

EISSN 2667-4440